Literature DB >> 9385045

5'-nucleotidase enzyme cytochemistry as a tool for revealing activated glial cells and malleable synapses in CNS development and regeneration.

S W Schoen1, G W Kreutzberg.   

Abstract

The demonstration of 5'-nucleotidase in neural tissue is achieved at both the light and electron microscopic levels by means of an enzyme cytochemical lead method, which is specific, sensitive and fast. By its activity this adenosine-producing ecto-enzyme (EC 3.1.3.5) outlines cellular surface membranes at the ultrastructural level. It is classically known as a marker of myelin and of astrocytes as well as (activated) microglial cells in the mature nervous system. In recent years, we discovered that 5'-nucleotidase is transiently active within synaptic clefts under conditions of development and regeneration. The enzyme is also seen at terminals in the mature retina and olfactory bulb, where spontaneous synaptic turnover occurs at adulthood. Thus, 5'-nucleotidase cytochemistry is useful in revealing sites of glial reactions and synaptic plasticity in CNS development and repair. It is assumed that the molecule affects terminal formation and cell motility due to dual functions in adenosine production and cell adhesion. Finally, at the light microscopic level, 5'-nucleotidase activity displays a dense neuropil staining which identifies topographic sub-units of certain parts of the nervous system, such as the striosomes of the basal ganglia, ocular dominance columns of the visual cortex and parasagittal bands of the cerebellum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385045     DOI: 10.1016/s1385-299x(96)00006-2

Source DB:  PubMed          Journal:  Brain Res Brain Res Protoc        ISSN: 1385-299X


  8 in total

1.  Stimulation of an alpha1-adrenergic receptor downregulates ecto-5' nucleotidase activity on the apical membrane of RPE cells.

Authors:  David Reigada; Xiulan Zhang; Ana Crespo; Johnathan Nguyen; Ji Liu; Klara Pendrak; Richard A Stone; Alan M Laties; Claire Mitchell
Journal:  Purinergic Signal       Date:  2006-08-11       Impact factor: 3.765

2.  Ecto-5'-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions.

Authors:  Elisabete Augusto; Marco Matos; Jean Sévigny; Ali El-Tayeb; Margaret S Bynoe; Christa E Müller; Rodrigo A Cunha; Jiang-Fan Chen
Journal:  J Neurosci       Date:  2013-07-10       Impact factor: 6.167

Review 3.  Purinergic neuron-glia interactions in sensory systems.

Authors:  Christian Lohr; Antje Grosche; Andreas Reichenbach; Daniela Hirnet
Journal:  Pflugers Arch       Date:  2014-04-06       Impact factor: 3.657

4.  NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors.

Authors:  Yin Lu; Paul A Rosenberg
Journal:  Brain Res       Date:  2007-05-04       Impact factor: 3.252

5.  Mice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations.

Authors:  Heidi O Nousiainen; Ileana B Quintero; Timo T Myöhänen; Vootele Voikar; Jelena Mijatovic; Mikael Segerstråle; Annakaisa M Herrala; Natalia Kulesskaya; Anitta E Pulkka; Tanja Kivinummi; Usama Abo-Ramadan; Tomi Taira; T Petteri Piepponen; Heikki Rauvala; Pirkko Vihko
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

6.  CD73 is a major regulator of adenosinergic signalling in mouse brain.

Authors:  Natalia Kulesskaya; Vootele Võikar; Marjaana Peltola; Gennady G Yegutkin; Marko Salmi; Sirpa Jalkanen; Heikki Rauvala
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

Review 7.  Purinergic Signaling in the Vertebrate Olfactory System.

Authors:  Natalie Rotermund; Kristina Schulz; Daniela Hirnet; Christian Lohr
Journal:  Front Cell Neurosci       Date:  2019-04-16       Impact factor: 5.505

Review 8.  Adenosine A2A Receptors as Biomarkers of Brain Diseases.

Authors:  Ana Moreira-de-Sá; Vanessa S Lourenço; Paula M Canas; Rodrigo A Cunha
Journal:  Front Neurosci       Date:  2021-07-16       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.